Semaglutide Resolves Nonalcoholic steatohepatitis, Finds Study Dr Kartikeya Kohli3 April 2021 6:30 AM GMTNonalcoholic steatohepatitis (NASH) is a common disease that is associated with increased morbidity and mortality, but treatment options are limited....
CT may identify patients with high-risk nonalcoholic fatty liver disease Hina Zahid1 Feb 2021 1:45 PM GMTLeesburg, VA, - According to ARRS' American Journal of Roentgenology(AJR), Fibrosis-4 (FIB-4) and multiple CT findings can identify patients with...
Statins use may reduce risk of NAFLD and liver cirrhosis: AJG Study MD Bureau13 Jan 2021 5:31 AM GMTNonalcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver disease worldwide, and a subset of patients with NAFLD...
Pioglitazione and bariatric surgery best for NASH treatment: Study Medha4 Jan 2021 3:22 PM GMTItaly: Weight loss and hepatic insulin improvement are promising approaches for the treatment of Non‐Alcoholic Steato‐Hepatitis (NASH), suggests a...
Stevia extract may reduce biomarkers of fatty liver disease Dr. Kamal Kant Kohli7 May 2020 12:45 PM GMTNon-caloric sweeteners (NCS) are food additives providing sweetness without calories and are considered safe and/or not metabolized by the liver. The...
